Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes.

Andersen, Thomas; Ueland, Thor; Aukrust, Pål; Nilsen, Dennis W; Grundt, Heidi; Staines, Harry; Kontny, Frederic

Andersen, Thomas; Ueland, Thor; Aukrust, Pål; Nilsen, Dennis W; Grundt, Heidi; Staines, Harry; Kontny, Frederic.

Afiliação

Andersen T; Department of Anesthesiology, Stavanger University Hospital, Stavanger, Norway.
Ueland T; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Aukrust P; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Nilsen DW; K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.
Grundt H; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Staines H; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Kontny F; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.

Front Cardiovasc Med ; 9: 867944, 2022.

Article em En | MEDLINE | ID: mdl-35669474

Palavras-chave

Podocan; acute coronary syndrome; biomarkers; chest pain; extracellular matrix; risk factors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google